MeNoPause Moxie Podcast Podcast Por Clinical Hormone Coach Marie Hoäg and Maggie Kuhn arte de portada

MeNoPause Moxie Podcast

MeNoPause Moxie Podcast

De: Clinical Hormone Coach Marie Hoäg and Maggie Kuhn
Escúchala gratis

Obtén 3 meses por US$0.99 al mes

The ONLY podcast talking about perimenopause and menopause prevention. We discuss the cultural, conventional, and ideological frameworks shaping perimenopause and menopause health in America today...and alternative approaches that influence the near and far future of women's mental and physical health, our families, our society, and our existence.© 2025 ™ Ciencias Sociales Higiene y Vida Saludable Medicina Alternativa y Complementaria Política y Gobierno
Episodios
  • Episode 13: The Five Clinical Categories: The Science Behind Why Women Respond Differently to HRT
    Dec 12 2025

    Why do some women feel incredible on hormone therapy while others struggle — even on the same HRT protocol?

    In this episode of the Me.No.Pause Moxie Podcast, Clinical Hormone Coach Marie Hoäg, MBA, explains the answer through the lens of Patient Clinical Categories — a framework developed from over two decades of clinical observation and thousands of female hormone patients.

    Marie and co-host Maggie Kuhn break down why women do not start hormone therapy from the same place, how gut health, toxin exposure, diet history, mindset, and overall health dramatically influence results, and why getting hormones balanced to the Hormone Sweet Spot™ is a process, not a prescription.

    Listeners will learn:

    • Why the same HRT system can produce different outcomes

    • How the Five Clinical Categories were developed and what they mean

    • What women in each category typically experience during hormone balancing

    • Why compliance, clinical hormone coaching, and gut health are critical to success

    • How understanding your category removes confusion, fear, and self-blame

    This episode brings clarity to a question women have been asking for years:
    “Why isn’t this working for me the way it works for someone else?”

    If you’ve ever felt discouraged, confused, or blamed yourself for not responding “fast enough” to hormone therapy, this conversation will fundamentally change how you understand your body — and your path to the Hormone Sweet Spot™.

    To learn your Clinical Category, start with the free Hormone Balance Test at HormoneBalanceTest.com.

    Más Menos
    55 m
  • Episode 12: FDA Black Box Warning Removal — Progress or Performance?
    Nov 25 2025

    The FDA removed the black box warning from estrogen—an announcement packaged as a major win for women’s health. But behind the headlines lies a different story. In this episode, Marie Hoäg breaks down what the FDA actually changed, what they left untouched, and why women must look deeper than the surface-level celebration.

    Marie and Maggie examine the coordinated media tour by FDA Commissioner Dr. Marty Makary, the inaccuracies and contradictions in his messaging, and why the science has not changed—only the narrative has. This symbolic shift opens the door for more low-dose prescribing, more confusion, and another generation of women being underdosed, misled, and medically underserved.

    Marie explains the real differences between low-dose HRT and therapeutic-dose restoration, what women can expect from each generation of hormone therapy, and how the system continues to profit from the symptoms of estrogen deficiency. This is a critical episode for every woman who refuses to settle for the status quo and wants clarity on what true hormone restoration really looks like.

    What You’ll Learn

    • Why the FDA removed the visual black box, but kept the warning
    • The industry motives behind the timing of this announcement
    • The contradictions in Dr. Makary’s messaging
    • Why low-dose HRT protocols cannot restore physiology
    • How four generations of HRT differ in their clinical outcomes
    • Why “talk to your doctor” is dangerous advice when doctors aren’t trained
    • How women can identify real hormone restoration vs. symptom management
    • What women should do now if they want true hormone replacement

    Listener Questions We Address

    • “If estrogen doesn’t cause cancer, why did the FDA keep the warning at all?”
    • “Why are doctors still pushing low-dose protocols?”
    • “What’s the real difference between an FDA-approved patch and therapeutic-dose HRT?”
    • “Should women still trust menopause guidelines if the data is incomplete?”
    • “What should women look for in a doctor who knows how to dose estrogen correctly?”

    If today’s episode made you question whether you need HRT—or whether your current therapy is truly serving you—trust that instinct. Your brain, your body, your family, and your long-term mental and physical health depend on you getting this right.

    To discover hormonal balance as you are supposed to experience it, book a complimentary discovery session at: advancedhormonebalancing.com

    Disclaimer

    The views expressed on the MeNoPause Moxie Podcast are based on over two decades of clinical observation, research, education, training, and personal experience by Marie Hoäg, MBA. It is presented for educational, informational, and entertainment purposes, and is not intended as medical, nutritional, or hormone replacement therapy (HRT) advice. Viewers and listeners are strongly encouraged to consult with a trained HRT professional before making any hormone-balancing decisions.

    Más Menos
    53 m
  • Episode 11: The FDA Finally Woke Up About Estrogen — But Women Are Still Left Deficient
    Nov 15 2025

    After twenty years of fear-based medicine, the FDA has finally woken up about estrogen (sort of) — admitting that the black box warning never should have existed.

    It’s validation, yes. But it’s also frustrating. Because while the FDA finally corrected the label, they didn’t correct the hormone restoration system. Women are still being prescribed low-dose, symptom-management therapies that leave them hormonally deficient, mentally foggy, and physically depleted. Basically, estrogen-starved.

    I’ve been teaching for years that estrogen was never the problem — the problem was targeted misinformation, fear, and a deliberate standard of care designed to keep women in need of more estrogen.

    In this episode, my producer and co-host, Maggie Kuhn, and I break down what the FDA got right, what they ignored, and why this moment — while historic — still falls short of real progress for women’s health.

    If you want to understand the difference between managing menopause and full hormone restoration, this is the episode to listen to.

    What You’ll Learn:

    • Why the FDA finally reversed the 2003 black box warning
    • The truth about the Women’s Health Initiative study and decades of misinformation
    • How estrogen protects the brain, heart, bones, and lifespan
    • Why women are still not receiving full hormone restoration
    • What needs to change in medical education and practice for women to get real results

    Disclaimer

    The views expressed on the Me.No.Pause Moxie Podcast are based on over twenty years of clinical observation, research, education, training, and personal experience by Clinical Hormone Coach Marie Hoäg, MBA. This content is for educational, informational, and entertainment purposes only and is not intended as medical or hormone therapy advice. Always consult a trained HRT professional before making any hormone-balancing decisions.

    Remember, everybody benefits when YOUR hormones are balanced.

    Más Menos
    1 h y 14 m
Todavía no hay opiniones